ArticleMolecular pharmaceutics2026
Influence of the Addition of Trace Amounts of Vinylpyrrolidone-Vinyl Acetate Copolymer (PVPVA) on the Crystallization of Celecoxib Glass.
Article in Molecular pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although polymers can prevent the crystallization of glassy drugs in amorphous solid dispersions, their stabilization mechanism requires further clarification for an efficient formulation design. This study examined the impact of adding trace amounts (2 or 5 w/w %) of vinylpyrrolidone-vinyl acetate copolymer (PVPVA) on the physical stability of celecoxib (CEL) glass using differential scanning calorimetry and broadband dielectric spectroscopy. Long-term isothermal crystallization studies from 35 to 60 °C revealed that CEL glass was significantly stabilized by the addition of trace amounts of PVPVA. Its stabilization was attributed to the effect of PVPVA on the nucleation process rather than on crystal growth. The addition of PVPVA slowed down the α-relaxation of CEL, whereas it accelerated Johari-Goldstein relaxation. Moreover, the addition of PVPVA effectively slowed down γ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.